UK: MHRA pragmatic and flexible approach allows special measures for clinical research under COVID-19

2024-02-29T16:18:52+00:00April 22nd, 2020|Categories: Covid-19, UK|Tags: , , , |

UPDATED ON April 22nd, 2020 In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) issued guidance on the management of clinical trials in response to the COVID-19 pandemic. "The MHRA will be as flexible and pragmatic as [...]

FDA: Update for medical device manufacturers in CARES Act

2024-02-26T10:57:19+00:00April 21st, 2020|Categories: Compliance, Covid-19, Regulatory, USA|Tags: , , |

FDA issued indications for medical device manufacturers within the CARES Act: Coronavirus Aid, Relief, and Economic Security Act. General provisions Medical device manufacturers are now required to report permanent discontinuance or interruption in manufacturing for the following categories of [...]

MDCG: possibility to postpone or undergo remote audit for medical device manufacturers during COVID-19

2024-02-26T16:52:20+00:00April 17th, 2020|Categories: Compliance, Covid-19, Europe, Regulatory|

The European Commission’s Medical Device Coordination Group (MDCG) issued a guidance temporarily allowing postponement or remote audits of medical device manufacturers necessary for the re-certification of CE marking and related requirements. Normally, manufacturers must undergo on-site audits by Notified [...]

FDA announces activities against COVID-19 in a new “At-a-Glance Summary”

2024-02-07T16:10:56+00:00April 17th, 2020|Categories: Clinical Trial, Compliance, Covid-19, Regulatory, USA|Tags: , , |

The FDA has posted a new “At-a-Glance Summary” that captures the agency’s major activities in the fight against COVID-19. The FDA has made a wide range of information regarding their activities available to the public on their COVID19 website. [...]

EU Members States and European Commission introduce mobile apps to gradually loosen confinement

2024-02-02T12:16:25+00:00April 17th, 2020|Categories: Covid-19, Europe|Tags: , , , , |

The EC and the EU Members States issued a toolbox for the use of mobile applications for contact tracing and alerting during the coronavirus pandemic. The toolbox is accompanied by guidance on data protection for such mobile app “Contact [...]

Switzerland: Exception for marketing of medical devices under COVID-19

2024-02-29T14:26:41+00:00April 16th, 2020|Categories: Clinical Trial, Covid-19, Europe, Switzerland|Tags: , , , |

The Swiss Federal Council issues a new regulation allowing marketing of devices that have not undergone a conformity assessment procedure. This will not exempt the manufacturer from proving performance of the device and essential requirement fulfilment.  This exception is [...]

Switzerland: Federal Council suspends tariffs for medical goods

2024-02-29T14:28:12+00:00April 16th, 2020|Categories: Clinical Trial, Covid-19, Europe, Switzerland|Tags: , , |

The Swiss Federal Council temporarily suspends custom duties on import medical goods. Such measure was set out to ease the import of medical equipment such as masks, gloves, disinfectant, protective goggles to face COVID-19 emergency in the country. The [...]

Columbia: procedures not related to the COVID-19 emergency

2024-02-01T16:43:42+00:00April 15th, 2020|Categories: Clinical Trial, Compliance, Covid-19, Regulatory|Tags: , , , |

In accordance with the provisions of Resolution No. 2020012926 of April 3, 2020 "By means of which temporary administrative measures are adopted within the framework of the health emergency declared by the National Government due to COVID-19" , it [...]

European Council modifies the EC proposal for MDR Delay

2024-02-07T16:07:23+00:00April 11th, 2020|Categories: Clinical Trial, Covid-19, Europe, MDR|Tags: , , , |

Few changes made and… review by Parliament announced on APRIL 16th! On April 7, 2020 the Presidency of Council of the European Union (EU) examined the European Commission (EC) proposal for MDR delayed application, including the urgent measures regarding devices [...]

International regulators emphasize the need for reliable evidence on COVID-19 treatment

2024-02-26T11:53:42+00:00April 9th, 2020|Categories: Clinical Trial, Covid-19, Europe|Tags: , , , |

Today, the international regulators have published a report highlighting their reflections on the development of potential COVID-19 therapies, clinical trials, and compassionate use programs. The report presents the results of a virtual meeting from April 2nd, 2020 on COVID-19 [...]

Go to Top